Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.5600
-0.0137 (-2.39%)
Oct 7, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
Life-transforming Therapies
636.00K

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
636.00K